The 1995 discovery of regulatory T cells underpins newer investigations pointing to potential allergy treatments and ...

The results of the study could improve immunotherapy treatment for patients with colorectal and other barrier-tissue cancers.

Detailed mapping of CD4⁺ T cells from children with systemic lupus erythematosus (SLE) has revealed distinct immune cell subsets with likely roles in disease pathogenesis, according to a study led by ...

Bicistronic CD19/CD22-directed CAR-T cell therapy achieved high remission rates and durable responses in pediatric B-ALL patients. One-year EFS and OS rates were 75.5% and 93.5%, respectively, with ...